| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | ST | Ordinary Shares, par value EUR 0.01 per share | Options Exercise | $412,542 | +12,300 | +18% | $33.54 | 80,913 | 04 Jan 2022 | Direct | F1, F2 |
| transaction | ST | Ordinary Shares, par value EUR 0.01 per share | Sale | $799,505 | -12,300 | -15% | $65.00 | 68,613 | 04 Jan 2022 | Direct | F1, F2, F3 |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | ST | Stock options to Buy | Options Exercise | $0 | -12,300 | -100% | $0.000000* | 0 | 04 Jan 2022 | Ordinary Shares, par value EUR 0.01 per share | 12,300 | $33.54 | Direct | F1, F4 |
| Id | Content |
|---|---|
| F1 | The transactions being reported on this Form 4 were executed pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 3, 2021. |
| F2 | Includes 64,424 unvested restricted stock units, of which 38,135 are subject to performance conditions. |
| F3 | Reflects the sale of an aggregate of 12,300 shares of common stock on January 4, 2022, at the weighted average sales price of $65.0004. The prices for these sales range from $65.00 to $65.03. The filer undertakes to provide, upon request by the Securities and Exchange Commission, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price. |
| F4 | The option grant became exercisable over four years at 25% per year, beginning on the first anniversary date of February 19, 2014. |